L-Glutamine and Gut Health: What the Research Shows

Jasmine Meagher, founder of Ritua
Jasmine Meagher, BSc Food Science and Nutrition
Founder, Ritua · 13 min read

Search glutamine and gut health and you will be told, within about four seconds, that it seals a leaky gut. The mechanism behind that claim is real. Glutamine genuinely is the fuel that the cells lining your small intestine prefer, and there is good laboratory work showing that when you take glutamine away from those cells, the seals between them loosen.

What is much thinner than the internet suggests is the human trial evidence, particularly in healthy adults. The strongest randomised data comes from people who were already unwell. The studies in healthy people are small, short, and mostly about exercise.

So here is the honest answer up front. The mechanism is real and not controversial: glutamine is the main respiratory fuel of the enterocyte, and those cells need it to build and hold the seals between them. The clinical evidence is another matter. The one strong randomised trial was run in patients with a diagnosed condition and measurably abnormal permeability. The exercise trials are tiny and disagree with each other. The large hospital trials were negative. There is no good randomised evidence that a healthy adult with a normal gut barrier gets anything measurable from supplementing glutamine, because that study has not been run.

Why the cells lining your small intestine run on glutamine

Most tissues burn glucose. The small intestine largely does not. The classic demonstration came from vascular perfusion studies of rat small intestine by Windmueller and Spaeth, which found that in fasted animals more than 36 per cent of the carbon dioxide produced by the intestine came from plasma glutamine and only 8 per cent from glucose. The gut wall pulls glutamine straight out of the blood supply and burns it.

Kim and Kim's review of glutamine in the intestine collects the human data: the intestine accounts for roughly 30 per cent of total body glutamine use, about a quarter of plasma glutamine is extracted by the small intestine on a single pass, and around three quarters of glutamine taken orally is absorbed into splanchnic tissue and metabolised there rather than reaching the rest of the body.

There is a structural reason for that appetite. The lining is a single layer of cells replaced every four to five days, and that turnover takes constant cell division, which glutamine feeds both as fuel and as raw material for the nucleotides new cells need. It is also why glutamine is called conditionally essential: in health you make enough, but under severe metabolic stress demand can outrun supply. What L-glutamine actually does works through that term and the biochemistry behind it.

What intestinal permeability is, and how it is measured

Intestinal permeability is a measurable property, not a metaphor. The lining is meant to be selectively leaky: nutrients cross through the cells, while the gaps between cells are sealed so only very small molecules slip through. Permeability testing asks how much larger molecules are getting through those gaps.

The standard method is a dual sugar test. You drink a measured dose of two sugars the body cannot metabolise. Mannitol is small and crosses easily, so it controls for how much you drank, how fast your stomach emptied and how well your kidneys are clearing it. Lactulose is larger and should barely cross unless the seals are loose. Both are collected in urine over five or six hours and reported as the lactulose to mannitol ratio, which is far more informative than either sugar alone. Some labs use rhamnose in place of mannitol.

A single ratio is not a diagnosis. Michael Camilleri's 2019 review in Gut makes the point that the barrier is more than the epithelial layer: it also includes the surface mucus and the local immune defences, and assessing it properly needs measurements beyond the sugars.

Leaky gut is a label, not a diagnosis

This is worth being blunt about. Leaky gut is a popular term that gets applied to a long list of symptoms, most of which have never been shown to correlate with a permeability measurement. It is not a recognised clinical diagnosis, and no doctor in Australia will write it on a referral.

Camilleri is direct about where the science sits. Stress states including endurance exercise, non steroidal anti inflammatory drugs and pregnancy do increase permeability, and inflammatory or ulcerating bowel diseases do produce a leaky barrier. But as that review puts it, no such disease can be cured by simply normalising barrier function, and it remains unproven that restoring it improves clinical symptoms. Raised permeability is usually a consequence of a disease process rather than its cause, and the popular framing reverses that.

The tight junction mechanism

The seals between intestinal cells are called tight junctions, built from claudins, occludin, tricellulin, junctional adhesion molecules and the zonula occludens family that anchors them to the cell's internal skeleton. They are not static structures. They remodel constantly and adjust their tightness in response to signals.

The cleanest evidence comes from deprivation experiments in Caco-2 cells, a human intestinal cell line. Take glutamine out of the culture medium and expression of claudin-1, occludin and ZO-1 drops sharply while measured permeability rises across several independent methods. Put glutamine back and barrier function recovers.

A 2014 study in the Journal of Applied Physiology by Zuhl and colleagues tested this directly. In Caco-2 cells heated to 41 degrees, adding glutamine at 4 and 6 millimolar raised occludin expression compared with no glutamine, alongside increases in heat shock factor 1 and heat shock protein 70. That is a plausible route by which glutamine could protect a barrier under stress, and it is worth saying plainly that this half of the study happened in a dish, not in a person.

The strongest human trial was in post infectious IBS

The best randomised evidence comes from a trial published in Gut in 2019 by Zhou and colleagues. The population was narrow and deliberately chosen: adults who had developed diarrhoea predominant irritable bowel syndrome after an enteric infection and who had a measurably elevated urinary lactulose to mannitol ratio at baseline. They were randomised, double blind, to 5 g of glutamine three times daily or matched placebo for eight weeks. Fifty four glutamine and 52 placebo participants completed.

The primary endpoint, a reduction of at least 50 points on the IBS Severity Scoring System, was reached by 43 of 54 participants taking glutamine (79.6 per cent) compared with 3 of 52 taking placebo (5.8 per cent), a 14 fold difference.

The permeability result matters as much as the symptom result, because it connects mechanism to outcome. In the glutamine group the lactulose to mannitol ratio fell from 0.11 to 0.05, and the paper reports that elevated ratios were normalised in the glutamine group but not in the control group.

Three caveats matter. The authors themselves called for large randomised trials to validate the findings. The effect size is unusually large for a nutrition trial, which is a reason for interest and also for caution. And every participant had a diagnosed condition plus a documented abnormality in the exact measure the treatment targeted. A result in that population does not tell you what happens in someone whose barrier is already working normally. The 15 g a day used here also sits far above a retail serve, which is covered in L-glutamine dosing: how much, and when.

Athletes, heat and endurance stress

Hard endurance exercise, especially in heat, reliably increases intestinal permeability. Blood is shunted away from the gut to working muscle and skin and the lining is transiently starved of oxygen. It is one of the few situations where a healthy person's permeability measurably changes, which makes it the natural place to test glutamine.

In the Zuhl trial, eight participants took glutamine for seven days before a 60 minute treadmill run. Permeability was higher on placebo than at baseline or after glutamine, at ratios of 0.0604, 0.0218 and 0.0272. Pugh and colleagues, in the European Journal of Applied Physiology in 2017, ran a dose response version in ten recreationally active men, each completing a placebo trial and three glutamine trials at 0.25, 0.5 and 0.9 grams per kilogram of fat free mass, two hours before a 60 minute run at 30 degrees. The lactulose to rhamnose ratio was lower on every glutamine dose than on placebo, with the largest effect at the highest dose. Gastrointestinal symptoms were low throughout and glutamine made no difference to how anyone felt.

The picture is not uniform. A 2022 randomised crossover trial in Temperature by Ogden and colleagues gave ten men a lower dose, 0.3 grams per kilogram of fat free mass, before an 80 minute exertional heat stress test and found no protection at all. The honest summary: the doses are large, participant numbers are in single or low double digits, every one of these trials was run in men, and a shift in a laboratory marker has not been shown to translate into anyone feeling better.

Burns and intensive care, and why that evidence does not transfer

Most of the enthusiasm for glutamine started in hospital nutrition. Severe burns and critical illness deplete glutamine stores, so supplementing looked like replacement. Early small trials were encouraging. The large ones were not. The REDOXS trial, in the New England Journal of Medicine in 2013, randomised 1223 critically ill adults with multiorgan failure across 40 intensive care units. Glutamine produced a trend toward increased 28 day mortality, 32.4 per cent versus 27.2 per cent, and significantly higher in hospital and six month mortality. The RE-ENERGIZE trial in 2022 randomised 1200 patients with severe burns averaging 33 per cent of body surface area, and found no reduction in time to discharge alive and no mortality difference.

Neither result tells you anything useful about a well person stirring a teaspoon into water. The doses were far higher, often given intravenously to people whose organs were failing, and the outcomes measured were survival and length of stay. What that literature does establish is a discipline worth borrowing: a compelling mechanism did not survive contact with a properly powered trial.

The microbiome evidence is one pilot study

You will see confident claims that glutamine reshapes the gut microbiome. In humans that rests on very little. The most cited work is a 2015 pilot study in Nutrition by de Souza and colleagues, which randomised 33 overweight and obese adults to 30 grams a day of either L-glutamine or L-alanine as a control, for 14 days. Sequencing showed differences in the Firmicutes and Actinobacteria phyla, and the ratio of Firmicutes to Bacteroidetes fell from 0.85 to 0.57 in the glutamine group while rising from 0.91 to 1.12 in the control group.

It is a genuinely interesting result. It is also 33 people, for a fortnight, at ten times a typical supplement serve, with no clinical outcome measured. The authors call it a pilot study and nobody has followed it up at scale. Anyone telling you glutamine fixes your microbiome is describing a hypothesis, not a finding.

The bottom line

Glutamine's relationship with the intestinal lining is one of the better established pieces of nutritional biochemistry. The gut burns it preferentially, cell culture work shows tight junction proteins depend on it, and one strong randomised trial found that in adults with post infectious IBS with diarrhoea and documented hyperpermeability, eight weeks of 5 g three times daily improved symptoms and the permeability measure alike.

What does not follow is the leap the marketing makes. Until someone runs the trial in healthy adults, the honest position is that we do not know. It is worth remembering, too, that glutamine is the most abundant free amino acid in the body and turns up in most protein foods, so anyone eating adequate protein already takes in several grams a day without supplementing.

If you are weighing glutamine against the other recovery products sold beside it, glutamine vs BCAAs vs protein sets out what each one supplies and what the evidence actually supports for each.

If you want to see what a plain glutamine supplement looks like without any of that framing, Ritua L-Glutamine is 100 per cent pure micronised L-glutamine in a 300 g pouch, roughly 100 serves. One serve is 3 g, about a teaspoon, stirred into 250 ml of cold water, a smoothie or a shake. No fillers, flavours or sweeteners, and it is third party lab tested. If you are managing a diagnosed digestive condition, that is a conversation for your doctor or a dietitian, not something to work out from a blog post.

This article is general information, not medical advice, and is not a substitute for guidance from your doctor, particularly if you are managing an existing health condition or taking medication.

Jasmine Meagher, founder of Ritua

Jasmine Meagher

BSc Food Science and Nutrition · Founder, Ritua

Jasmine founded Ritua to bring evidence-based, TGA-compliant supplements to Australian women. She writes about the research behind every ingredient Ritua sells.

Common questions

Is leaky gut a real medical diagnosis?

No. Intestinal permeability is a real, measurable property of the gut lining, and it can be tested. Leaky gut is a popular label applied loosely to a wide range of symptoms, and it is not a recognised clinical diagnosis. Camilleri's 2019 review in Gut notes that inflammatory bowel diseases do produce a leaky barrier, but that no such disease has been cured by normalising barrier function alone.

How is intestinal permeability actually measured?

Most commonly with a dual sugar test. You drink a set dose of lactulose, a large molecule that should barely cross the lining, together with mannitol, a small one that crosses easily and acts as a control for dose, gastric emptying and kidney clearance. Both are collected in urine and reported as the lactulose to mannitol ratio. Some laboratories use rhamnose instead of mannitol.

Why is glutamine described as the fuel of the gut lining?

Because the intestine burns it in preference to glucose. Perfusion studies in rats found that more than 36 per cent of the carbon dioxide produced by the fasted intestine came from plasma glutamine and only 8 per cent from glucose. In humans the intestine accounts for roughly 30 per cent of total glutamine use, and the lining is replaced every four to five days.

What dose did the IBS trial use?

Zhou and colleagues used 5 g three times daily, so 15 g a day, for eight weeks, in adults who had developed diarrhoea predominant IBS after an enteric infection and who had elevated permeability at baseline. That is a trial protocol in a diagnosed patient group under study conditions, well above a typical supplement serve, and not a self treatment recommendation.

Does the research apply to healthy adults?

Not directly. The strongest trial recruited people with a diagnosed condition and an abnormal permeability measurement. The exercise trials were small groups of men under heat or endurance stress, a state in which permeability genuinely rises. There is no good randomised evidence about a healthy adult with a normal gut barrier, because that trial has not been run.

Do we know glutamine changes the gut microbiome?

Not with any confidence. The main human study is a 2015 pilot in 33 overweight and obese adults given 30 grams a day for 14 days, which found a shift in the Firmicutes to Bacteroidetes ratio compared with a control amino acid. It is a single small pilot at a very high dose, with no clinical outcome measured and no large follow up.

Sources

Back to blog

Ritua

Build your daily ritual

Clean, science-led supplements. Australian made.

Shop the range